Erratum to: The Clinical Effectiveness of Ranibizumab Treat and Extend Regimen in nAMD: Systematic Review and Network Meta-Analysis
Adv Ther
.
2017 May;34(5):1233.
doi: 10.1007/s12325-017-0533-8.
Authors
Andriy Danyliv
1
,
Julie Glanville
2
,
Rachael McCool
2
,
Alberto Ferreira
3
,
Adrian Skelly
3
,
Ruth Pulikottil Jacob
4
Affiliations
1
Novartis Ireland Limited, Dublin, Ireland. andrii.danyliv@novartis.com.
2
York Health Economics Consortium, University of York, York, UK.
3
Novartis Pharma AG, Basel, Switzerland.
4
Novartis Pharmaceuticals UK Limited, Surrey, UK.
PMID:
28417317
PMCID:
PMC5427133
DOI:
10.1007/s12325-017-0533-8
No abstract available
Publication types
Published Erratum